SONNET BIOTHERAPEUTICS
Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action. The company 's proprietary FHAB™ (Fully Human Albumin Binding) technology enables the development of innovative targeted biologic drugs with enhanced single- or bi-specific mechanisms. The FHAB™ platform utilizes a fully human single-chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. Son... net’s FHAB construct attaches to albumin in the bloodstream, which significantly enhances the pharmacokinetics of the active drug substance. It also naturally accumulates at inflammation sites, including tumors, thereby potentiating delivery to target tissues. The Sonnet platform is differentiated in that FHAB utilizes a fully human sequence, with a human glycosylation profile that can be manufactured using a standard CHO process.
SONNET BIOTHERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2011-01-01
Address:
Princeton, New Jersey, United States
Country:
United States
Website Url:
http://www.sonnetbio.com
Total Employee:
1+
Status:
Active
Contact:
609-375-2227
Email Addresses:
[email protected]
Total Funding:
30.75 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Domain Not Resolving
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-04-01 | Chanticleer Holdings | Chanticleer Holdings acquired by Sonnet BioTherapeutics | N/A |
Official Site Inspections
http://www.sonnetbio.com Semrush global rank: 4.7 M Semrush visits lastest month: 2.05 K
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Sonnet BioTherapeutics"
Sonnet BioTherapeutics, Inc. (SONN)
Sonnet BioTherapeutics is taking the fight directly to cancer using its proprietary FHAB™ technology to empower innovative targeted biologic drugs.See details»
Company Information :: Sonnet BioTherapeutics, Inc.
Headquartered in Princeton, NJ, Sonnet BioTherapeutics is a clinical stage biotechnology company with a proprietary platform for innovating biologic drugs of single- or bi-specific mechanisms.See details»
Sonnet BioTherapeutics - Crunchbase Company Profile …
Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action. The company 's proprietary FHAB™ (Fully Human Albumin Binding) technology enables the development …See details»
Sonnet BioTherapeutics Holdings, Inc. (SONN) - Yahoo Finance
See the company profile for Sonnet BioTherapeutics Holdings, Inc. (SONN) including business summary, industry/sector information, number of employees, business summary, corporate …See details»
Sonnet BioTherapeutics - LinkedIn
As experts in cytokine biology, our clinical stage pipeline comprises five cytokine-derived therapeutic candidates, with our lead proprietary compound, SON-1010, in Phase 1 development. Closely ...See details»
Company Description - Stock Analysis
Nov 18, 2024 Sonnet BioTherapeutics Holdings, Inc., a biotechnology company, owns a platform for biologic medicines of single or bifunctional action. The company develops fully human …See details»
Sonnet BioTherapeutics - VentureRadar
Website: http://sonnetbio.com/ Founded in 2011, Sonnet BioTherapeutics is an oncology-focused biotechnology company with a proprietary platform for innovating ...See details»
Sonnet BioTherapeutics - Craft
Oct 4, 2024 Sonnet BioTherapeutics has 5 employees at their 1 location and $147.81 k in annual revenue in FY 2023. See insights on Sonnet BioTherapeutics including office locations, …See details»
Sonnet BioTherapeutics Holdings, Inc. (SONN) - Yahoo Finance
Find the latest Sonnet BioTherapeutics Holdings, Inc. (SONN) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Management Team :: Sonnet BioTherapeutics, Inc. (SONN)
Jay Cross joined Sonnet BioTherapeutics in May 2019 and serves as the Chief Financial Officer. Prior to Sonnet, Mr. Cross was a Managing Director with Chardan Capital’s healthcare …See details»
Overview, News & Similar companies - ZoomInfo.com
Feb 7, 2023 Sonnet BioTherapeutics contact info: Phone number: (609) 375-2227 Website: www.sonnetbio.com What does Sonnet BioTherapeutics do? Founded in 2015, Sonnet …See details»
Sonnet BioTherapeutics Holdings Inc - Bloomberg.com
6 days ago Stock analysis for Sonnet BioTherapeutics Holdings Inc (SONN:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company …See details»
Sonnet BioTherapeutics Holdings, Inc. (SONN) - Stock Analysis
3 days ago Website https://www.sonnetbio.com. Full Company Profile. Financial Performance. In 2023, SONN's revenue was $147,805, a decrease of -57.76% compared to the previous year's …See details»
Board of Directors :: Sonnet BioTherapeutics, Inc. (SONN)
Nailesh Bhatt has served on Sonnet’s board of directors since July 2018. Since January 2018, Mr. Bhatt has been the Chief Executive Officer and a Board Member of VGYAAN Pharmaceuticals …See details»
Sonnet BioTherapeutics Announces Preclinical Data Supporting Its ...
Apr 8, 2022 PRINCETON, NJ / ACCESSWIRE / April 8, 2022/ Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic …See details»
SONN.O - | Stock Price & Latest News | Reuters
Nov 22, 2024 Get Sonnet Biotherapeutics Holdings Inc (SONN.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsSee details»
Sonnet BioTherapeutics Holdings, Inc. (SONN) Stock Price & News ...
Get the latest Sonnet BioTherapeutics Holdings, Inc. (SONN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading …See details»
Sonnet BioTherapeutics Provides 2021 Business Update
Mar 29, 2021 PRINCETON, NJ / ACCESSWIRE / March 29, 2021 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company …See details»
Technology :: Sonnet BioTherapeutics, Inc. (SONN)
A Modular Drug Development Platform. Our Fully Human Albumin-Binding (F H AB) construct is the foundation of a fully modular technology that enables the design of single or bifunctional …See details»